HGV
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Hygrovest Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-13.81%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Hygrovest Ltd. operates as an investment holding company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-01-22. The firm concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and debt securities. The firm is focused on opportunities in listed small cap equities markets, including undervalued, well-managed growth companies, often founder-led, that are off the radar of the broader investment community; undervalued securities where the Company seeks to realize value; and situations that are dependent on a specific corporate action, such as mergers, liquidations, tender offers and divestments. The Company’s investment manager is HD Capital Partners Pty Ltd (HD).
📈 Performance
Price History
-76.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.05
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in HGV
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
65 weeks
💵 Average investment amount
$750
⏰ Last time a customer invested in HGV
515 days
HGV investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in HGV also invest in...
Hygrovest Ltd. operates as an investment holding company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-01-22. The firm concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and debt securities. The firm is focused on opportunities in listed small cap equities markets, including undervalued, well-managed growth companies, often founder-led, that are off the radar of the broader investment community; undervalued securities where the Company seeks to realize value; and situations that are dependent on a specific corporate action, such as mergers, liquidations, tender offers and divestments. The Company’s investment manager is HD Capital Partners Pty Ltd (HD).
🙌 Performance (5Yr p.a)
-9.80%
📊 Share price
$0.05 AUD
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.59%
📊 Share price
$102.85 AUD
🧱 MATERIALS
⛳️ DIVERSIFIED
💸 FINANCIALS
🇦🇺 AUSTRALIA
VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
4.90%
📊 Share price
$96.67 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
18.33%
📊 Share price
$63.14 AUD
🇺🇸 UNITED STATES
📈 HIGH PRICE GROWTH
Ingenia Communities Group engages in managing and developing a portfolio of retirement and lifestyle communities. The company is headquartered in Sydney, New South Wales and currently employs 1,400 full-time employees. The company went IPO on 2004-07-01. The company owns, operates, and develops a portfolio of lifestyle and holiday communities across key urban and coastal markets. The company operates in five segments: Lifestyle Development; Lifestyle Rental; Ingenia Gardens; Ingenia Holidays; and Fuel, Food & Beverage Services. The Lifestyle Development segment comprises of the development and sale of lifestyle homes. The Lifestyle Rental segment comprises of long-term accommodation within lifestyle and rental communities. The Ingenia Gardens segment consists of rental villages. The Ingenia Holidays segment comprises of tourism and rental accommodation within holiday parks. The Fuel, Food & Beverage Services segment consists of the Company’s investment in service station and food & beverage operations adjoined to Ingenia Holiday communities. Its subsidiaries include Bridge Street Trust, Browns Plains Road Trust, Casuarina Road Trust, Edinburgh Drive Trust, and Garden Villages Management Trust.
🙌 Performance (5Yr p.a)
2.20%
📊 Share price
$5.63 AUD
🏠 REAL ESTATE
🕊️ SOCIALLY AWARE
Want more shares? Try these...
Health House International Ltd. is an international distributor of medicinal cannabis. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-07-28. The company is specialized importer, exporter, consolidator and distributor of medicinal cannabis products. The firm distributes medicinal cannabis products to pharmacies, prescribers, specialist medicinal cannabis clinics and researchers across Australasia. The company supplies pharmacies, hospital, government departments, veterinarians and other wholesalers with medicinal cannabis and general pharmaceutical products across the United Kingdom and Europe. The products distributed by the Company include iX Biopharma’s Xativa, which is formulated using WaferiX, which is sublingual delivery technology, and Zelira Therapeutics’ cannabinoid-based customized medicines, including HOPE1, HOPE2 and Zenivol oil blended with pharmaceutical-grade sunflower oil. The company distributes Levin Health’s cannabinoid-based, chronic pain medicines, such as LEVIN CBD 100 and LEVIN Balance 10:12.
📊 Share price